“Technology moves too quickly for the world of academic publishing. That’s a long held belief by many but also a common topic of conversation among those working in digital health today. How to best study efficacy can be a tricky subject for digital health, however, the argument that efficacy data is unimportant rarely enters the debate — it is, especially for those companies that hope to convince payers that their services are worthy of reimbursement. Of course, the benefits of rigorous study go well beyond that in many cases, too.”
Article
Brian Dolan, mobihealthnews, 22 January 2013
